Development of a microfluidic isothermal amplification nucleic acid detection (mFIND) platform for simultaneous detection of respiratory pathogens
Biosensors and Bioelectronics · 2026
DOI: 10.1016/j.bios.2026.119096 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2026. Verfasst von Peiyan He und 7 weiteren Autor:innen. Beteiligte Einrichtung: Jiaxing Center for Disease Control and Prevention, No. 486, Wen Qiao Road, Jiaxing, Zhejiang, China. Hauptthemen laut MEDLINE: Nucleic Acid Amplification Techniques, SARS-CoV-2, COVID-19, Influenza A virus. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Key Technologies Research and Development Program, National Key Research and Development Program of China.
Abstract (Originalsprache)
We developed the mFIND platform, a centrifugal microfluidic isothermal amplification system for simultaneous detection of influenza A/B (FLUAV/FLUBV), SARS-CoV-2, and RSV - key agents of acute respiratory infections. The chip integrates four independent reaction chambers preloaded with lyophilized reagents, enabling room-temperature storage and a simplified two-step workflow. A portable analyzer automates sample metering, isothermal amplification (41 ± 0.4 °C), and real-time fluorescence monitoring, completing detection within 15 min with an ultra-low reaction volume of 2.5 μL per chamber. The platform achieved limits of detection of 2 copies/test for FLUAV/FLUBV and 5 copies/test for SARS-CoV-2/RSV, with no cross-reactivity against 23 non-target pathogens. Clinical validation using 236 positive samples showed 100% positive and negative agreement with qPCR. The mFIND platform combines rapid turnaround, simplified workflow, low reagent consumption, and parallel processing of four samples (16 targets), positioning it as a practical point-of-care nucleic acid testing solution for decentralized settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiaxing Center for Disease Control and Prevention, No. 486, Wen Qiao Road, Jiaxing, Zhejiang, China.
- Suzhou Cyansail Tech Co. Ltd., Floor 2, Building 14, 25 Datong Road, Suzhou, Jiangsu, China.
- Jiaxing Dawnsail Biotech Co., Ltd., Floor 1, Building 1, 501 Changsheng nan Road, Jiaxing, Zhejiang, China.
- Faculty of Veterinary Medicine, Chiang Mai University, Mae Hia, Muang, Chiang Mai, 50100, Thailand.
- Jiaxing Dawnsail Biotech Co., Ltd., Floor 1, Building 1, 501 Changsheng nan Road, Jiaxing, Zhejiang, China. Electronic address: huiyang@dawnsailbio.com.
- Centre for Clinical Laboratory, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, 310006, China; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliate…
Förderung
- Key Technologies Research and Development Program
- National Key Research and Development Program of China
Zitieren
APA
He, P., Feng, Y., Zhou, X., Yan, Y., Lu, C., Pringproa, K., Yang, H., & Liang, L. G. (2026). Development of a microfluidic isothermal amplification nucleic acid detection (mFIND) platform for simultaneous detection of respiratory pathogens. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2026.119096
Vancouver
He P, Feng Y, Zhou X, Yan Y, Lu C, Pringproa K, et al. Development of a microfluidic isothermal amplification nucleic acid detection (mFIND) platform for simultaneous detection of respiratory pathogens. Biosensors and Bioelectronics. 2026. doi:10.1016/j.bios.2026.119096
BibTeX
@article{He2026,
author = {He, Peiyan and Feng, Yating and Zhou, Xiaojie and Yan, Yong and Lu, Cheng and Pringproa, Kidsadagon and Yang, Hui and Liang, Li-Guo},
title = {Development of a microfluidic isothermal amplification nucleic acid detection (mFIND) platform for simultaneous detection of respiratory pathogens},
journal = {Biosensors and Bioelectronics},
year = {2026},
doi = {10.1016/j.bios.2026.119096}
}
EUVIMED